Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – N-c doai
Reexamination Certificate
2005-03-08
2005-03-08
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
N-c doai
C514S512000, C514S546000, C514S551000, C514S625000, C549S475000, C554S052000, C554S056000, C554S063000, C558S275000, C558S276000, C560S014000, C560S033000, C560S155000, C560S165000, C560S173000
Reexamination Certificate
active
06864285
ABSTRACT:
The present invention relates to novel covalent derivatives of alkanolamides of monocarboxylic and dicarboxylic acids with aminoalcohols of general formula (I) which can usefully be used as agonists of the CB2 cannabinoid receptor and hence as drugs active in pathological conditions which can be controlled by stimulation and/or costimulation of this receptor
REFERENCES:
patent: WO 9618391 (1996-06-01), None
patent: WO 9618600 (1996-06-01), None
Comelli Cristina
Della Valle Francesco
Della Valle Maria Federica
Marcolongo Gabriele
Innovet Italia S.r.l.
Kalow & Springut LLP
Raymond Richard L.
LandOfFree
Covalent derivatives of alkanolamides of monocarboxylic and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Covalent derivatives of alkanolamides of monocarboxylic and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Covalent derivatives of alkanolamides of monocarboxylic and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3402327